x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Derms and Conditions

Hear from the leading dermatologists and experts as they discuss the hottest topics in dermatology. Tune in for clinical practice tips and treatment pearls you can implement quickly and efficiently into your busy practices!

health & fitness medicine

All Episodes

35:10

A Deep Dive Into IL-17 Inhibition and Bimekizumab for...

Derms and Conditions ·

2024/01/04

In this episode of Derms and Conditions, Andy Blauvelt, MD, joins James Q. Del Rosso, DO, to discuss IL-17 inhibition, with a focus on bimekizumab as a treatment for psoriasis. Bimekizumab is unique for inhibiting both IL-17A and IL-17F, demonstrating higher efficacy and a favorable safety profile. Dr Blauvelt highlights the drug's mechanism of action and covers its approval process, global use, and notable data. He emphasizes its efficacy in achieving Psoriasis Area Severity Index 100 (PASI 100)

en

30:52

Final Thoughts from 2023: Highlights from Podcasts Past…

Derms and Conditions ·

2023/12/28

In this episode of Derms and Conditions, our host, Dr James Q. Del Rosso, reflects on the past year of podcasting, offering a rich summary of key dermatologic topics discussed throughout 2023. To start, the episode delves into highlights from an interview with Dr Shane Chapman, who specializes in skin cancer. Dr Chapman shares insights into nonsurgical options for treating nonmelanoma skin cancer, focusing on strategies for cases of squamous cell carcinoma and nodular basal cell carcinoma that may

en

26:19

Untangling the Questions and Challenges in Patients...

Derms and Conditions ·

2023/12/21

In episode 67 of Derms and Conditions, our host, Dr James Q. Del Rosso, sits down again with Dr Jeff Donovan, a board-certified dermatologist who practices in Whistler, Canada, with his dermatology clinic dedicated solely to the management of hair disorders, for part two of their discussion on alopecia areata and other hair loss conditions. Dr Donovan begins the discussion by addressing autoimmune thyroid disease associated with alopecia areata and the appropriate laboratory interpretation and

en

25:45

Untangling the Questions and Challenges in Patients...

Derms and Conditions ·

2023/12/14

In episode 66 of Derms and Conditions, our host, Dr James Q. Del Rosso, sits down with Dr Jeff Donovan, a board-certified dermatologist who practices in Whistler, Canada, with his dermatology clinic dedicated only to management of hair disorders. In part one of this series, they discuss how to approach patients with alopecia areata. Dr Donovan starts by discussing conditions that can mimic alopecia areata and when a biopsy may be needed to confirm the diagnosis, prompting him to share his

en

22:42

Does Bimekizumab Raise the Bar of Success for...

Derms and Conditions ·

2023/12/07

In episode 65 of Derms and Conditions, our host, James Q Del Rosso, DO, chats with Ted Rosen, MD, Professor of Dermatology at Baylor College of Medicine and Chief of Dermatology Service at Michael E. DeBakey Veterans Affairs Medical Center, to discuss new developments in psoriasis treatment. They begin by discussing the current psoriasis treatment landscape and the perception that with effective biologics now on the market, there are no longer any unmet needs in psoriasis treatment. They reflect on

en

25:26

Beyond the Knife: Practical Nonsurgical Options for...

Derms and Conditions ·

2023/11/21

In Episode 64 of Derms and Conditions, our host, Dr James Q. Del Rosso sits down with Dr Shane Chapman, Chair of the Department of Dermatology at Dartmouth Hitchcock Medical Center, to discuss nonsurgical approaches to treating nonmelanoma skin cancer. Dr. Chapman begins by discussing topical treatment options for nonmelanoma skin cancer for patients who are not candidates for surgery. He comments on the use of intralesional chemotherapy for keratoacanthomas or squamous cell carcinomas in poorly

en

25:29

What is Dr Adam Friedman Up To Now?

Derms and Conditions ·

2023/11/09

In Episode 63 of Derms and Conditions, our host, James Q. Del Rosso, DO, sits down with Adam Friedman, MD, to discuss some important topics in dermatology, including a comprehensive resource for portraying skin conditions and his research findings relating to sensitive skin. Dr Friedman begins by describing his atlas project, created to address a gap in dermatology in the limited way textbooks and atlases portray skin conditions. The Full Spectrum of Dermatology: A Diverse and Inclusive Atlas is a

en

21:17

Live From Las Vegas! Greatest Hits from Fall Clinical...

Derms and Conditions ·

2023/10/26

In this episode of Derms and Conditions, Dr. Jim Del Rosso and Dr. Gary Goldenberg discuss some of the highlights from the meeting. These include recent FDA approvals such as bimekizumab for psoriasis and the triple topical combination for acne vulgaris, the newer nonsteroidal topical agents, tapinarof and roflumilast, and their relevant clinical use, the significance of narrow-spectrum oral antibiotic therapy with sarecycline as compared to other oral tetracycline with regard to antibiotic

en

22:58

Once Is Not Enough: Round 2 on Therapeutic Insights

Derms and Conditions ·

2023/10/05

In episode 61 of Derms and Conditions, our host, James Q. Del Rosso, DO, presents a self-made episode where he clarifies key points on many therapies relevant to every-day clinical practice. First, he discusses topical alpha-agonist therapy for persistent facial erythema (PFE) of rosacea. Long-term data shows that daily use of either topical oxymetazoline or brimonidine appears to “reset” (lower) the baseline level of PFE in patients with rosacea. Next, he talks about sub-antibiotic dosing of

en

23:49

A Closer Look at How to Address Skin Care With Your...

Derms and Conditions ·

2023/09/21

In episode 60 of Derms and Conditions, our host, James Q. Del Rosso, DO, sits down with Cheri Frye, MD, the residency program director of dermatology at Howard University. The 2 discuss how to address skin care with patients and key products that should be incorporated into a skin care routine for specific skin types and populations. Dr Del Rosso begins by asking Dr Frye about her approach to advising the general patient on their skin care. She notes that interest in skin care has grown

en

25:04

Improving Our Understanding of How Drugs Work:...

Derms and Conditions ·

2023/09/07

In Episode 59 of Derms and Conditions, our host, James Q. Del Rosso, DO, continues his conversation with Christopher Bunick, MD, PhD, an associate professor of dermatology at Yale University School of Medicine who performs specialized research on novel treatments and therapies. After discussing sarecycline for acne in part 1, the two switch gears to monoclonal antibodies. Dr Bunick begins by discussing dupilumab, an IL-4 and IL-13 blocker with significant clinical efficacy and a favorable safety

en

23:03

Removing the Confusion Surrounding Some Commonly Used...

Derms and Conditions ·

2023/08/24

In episode 58 of Derms and Conditions, our host, Dr James Q. Del Rosso, presents a self-made episode where he discusses some clarifications regarding commonly misunderstood therapies in dermatology. Dr Del Rosso begins by discussing the use of benzoyl peroxide (BPO) for papulopustular rosacea and notes that many providers are hesitant to use this treatment given the perceived irritant effects. He notes that the microencapsulated BPO 5% cream (FDA approved EPSOLAY®), specifically formulated to allow

en

22:58

Improving Our Understanding of How New and...

Derms and Conditions ·

2023/08/03

In episode 57 of Derms and Conditions, our host, James Q. Del Rosso, DO, sits down with Christopher Bunick, MD, PHD, an associate professor of dermatology at Yale University School of Medicine who performs specialized dermatologic research utilizing x-ray crystallography and other novel techniques. The 2 discuss research findings surrounding new information on properties that differentiate the activity of antibiotics, with specific data on how narrow spectrum activity with sarecycline differs from

en

23:43

Can Teledermatology Be a Win-Win for Patients and...

Derms and Conditions ·

2023/07/20

In episode 56 of Derms and Conditions, our host James Q. Del Rosso, DO, sits down with Marc Serota, MD, a dermatologist in private practice in Denver who is triple board certified in dermatology, allergy and immunology, and pediatrics and serves as an adjunct faculty at the University of Colorado. The 2 discuss teledermatology and how Dr Serota uses it to increase access to care and develop additional revenue streams. They begin by recounting how teledermatology became as widespread as it is and its

en

25:43

The Right "Guy" For the Job to Bring Us Up to Date:...

Derms and Conditions ·

2023/07/06

In episode 55 of Derms and Conditions, our host James Q. Del Rosso, DO, sits down with Guy Webster, MD, PhD, FAAD, a clinical professor of dermatology at Jefferson Medical College. The 2 discuss new developments in the pathophysiology and management of acne as well as key pearls and pitfalls when using topicals, antibiotics, and isotretinoin. Dr Del Rosso begins by asking Dr Webster about any major changes to acne dogma over the last few decades. Dr Webster points out that while our knowledge is

en

22:38

Alternative Approaches: A Thoughtful Conversation on...

Derms and Conditions ·

2023/06/22

In episode 54 of Derms and Conditions, our host James Q. Del Rosso, DO, sits down with Raja Sivamani, MD, MS, AP, a board-certified dermatologist who practices at the Pacific Skin Institute and runs the Integrative Dermatology Symposium through LearnSkin. They discuss the concept of integrative dermatology, which involves uniting principles from pharmaceuticals, diet, nutrition, supplements, and probiotics to deliver holistic care. Dr Del Rosso begins by asking how to learn more about the science

en

27:21

Thinking Through Diagnostic Challenges in Patients...

Derms and Conditions ·

2023/06/08

In episode 53 of Derms and Conditions, our host James Q. Del Rosso, DO, continues his conversation with Matt Zirwas, MD, a dermatologist in Columbus, Ohio, and founder of the Bexley Dermatology Research Clinic. After reviewing localized eczematous dermatitis in part 1, they switch gears to discuss adults with scattered eczematous dermatitis in part 2. Dr. Zirwas shares several pearls for differentiating among atopic dermatitis, psoriasis, photosensitive dermatitis, CTCL, and contact dermatitis, and

en

30:39

Sunscreens 2023: Where Are We Now and What Else Can...

Derms and Conditions ·

2023/05/18

In episode 52 of Derms and Conditions, our host James Q. Del Rosso, DO, sits down with Darrell Rigel, MD, MS, a Clinical Professor of Dermatology at the Mount Sinai Icahn School of Medicine and a world leader in research and patient care for melanoma and other skin cancers. The two discuss the current state of sunscreens and how to address the most common questions that patients have in the office. Patients often wonder if they need to use sunscreen when the UV index is low, if sunscreen is

en

27:55

Thinking Through Diagnostic Challenges in Patients...

Derms and Conditions ·

2023/05/04

In episode 51 of Derms and Conditions, our host James Q. Del Rosso, DO, sits down with Matt Zirwas, MD, a dermatologist in Columbus, Ohio, and founder of the Bexley Dermatology Research Clinic. The two discuss how to approach a patient with an unspecified dermatitis. Dr. Zirwas begins by recounting his experiences with dermatitis unspecified, also known as non-atopic adult dermatitis, and how he became interested in treating this complex disease. Dr. Del Rosso asks how to differentiate between this

en

21:24

From the Research Center to the Clinic: Biologics and...

Derms and Conditions ·

2023/04/27

In episode 50 of Derms and Conditions, our host James Q. Del Rosso, DO, continues his conversation with Andrew Blauvelt, MD, MBA, a clinical trials investigator and former President and Owner of the Oregon Medical Research Center. Dr. Blauvelt has conducted almost 200 clinical trials on biologics and JAK inhibitors for the treatment of psoriasis and atopic dermatitis. While part 1 of this series focused on psoriasis, part 2 takes a deep dive into new therapies for atopic dermatitis. Dr. Blauvelt

en

151 results

Similar Podcasts

Доктор Тройняшкин

Доктор Тройняшкин

The Dry Eye Treatment PODCAST

Dry Eye Treatment

Différent et alors ?

PATRICK SULAY

Kyle Kingsbury Podcast

Kyle Kingsbury

The Real Weight Loss Coach

Matty Lansdown